1,2-diphenylethene derivatives for treatment of immune diseases
The invention provides novel 1,2-diphenylethene derivatives and pharmaceutically acceptable salts thereof, the process for production of these compounds and their pharmaceutical composition and the use of these compounds as modulators of T-cells, neutrophils, macrophages and their associated cytokines as agents for treating immune, inflammatory and auto-immune diseases.
Glaxo Group Limited
C C C C A C C C A C A C
C07D C07D C07C C07C A61P C07C C07C C07C A61P C07D A61P C07C
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Genhui Wei Jianxiong John M.
Chen Liu Li Webster